Impact of the COVID-19 Outbreak on the Management of Patients with Cancer
- PMID: 32445083
- PMCID: PMC7243433
- DOI: 10.1007/s11523-020-00721-1
Impact of the COVID-19 Outbreak on the Management of Patients with Cancer
Abstract
The coronavirus SARS-CoV-2 (COVID-19) outbreak is having a profound impact on the management of patients with cancer. In this review, we comprehensively investigate the various aspects of cancer care during the pandemic, taking advantage of data generated in Asia and Europe at the frontline of the COVID-19 pandemic spread. Cancer wards have been subjected to several modifications to protect patients and healthcare professionals from COVID-19 infection, while attempting to maintain cancer diagnosis, therapy, and research. In this setting, the management of COVID-19 infected patients with cancer is particularly challenging. We also discuss the direct and potential remote impacts of the global pandemic on the mortality of patients with cancer. As such, the indirect impact of the pandemic on the global economy and the potential consequences in terms of cancer mortality are discussed. As the infection is spreading worldwide, we are obtaining more knowledge on the COVID-19 pandemic consequences that are currently impacting and may continue to further challenge cancer care in several countries.
Similar articles
-
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group.Oncologist. 2020 Jun;25(6):e936-e945. doi: 10.1634/theoncologist.2020-0213. Epub 2020 Apr 27. Oncologist. 2020. PMID: 32243668 Free PMC article. Review.
-
Incorporating telemedicine as part of COVID-19 outbreak response systems.Am J Manag Care. 2020 Apr;26(4):147-148. doi: 10.37765/ajmc.2020.42784. Am J Manag Care. 2020. PMID: 32270980
-
[Clinical consideration and management of coronavirus disease 2019].Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):222-228. doi: 10.3760/cma.j.cn50113-20200220-00056. Zhonghua Gan Zang Bing Za Zhi. 2020. PMID: 32306656 Chinese.
-
The COVID-19 outbreak: a snapshot from down under.Expert Rev Anticancer Ther. 2020 Jun;20(6):433-436. doi: 10.1080/14737140.2020.1766974. Epub 2020 May 18. Expert Rev Anticancer Ther. 2020. PMID: 32419533 No abstract available.
-
The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.J Med Virol. 2020 Jul;92(7):786-790. doi: 10.1002/jmv.25918. Epub 2020 Apr 29. J Med Virol. 2020. PMID: 32320066 Free PMC article. Review.
Cited by
-
Patient safety associated with the surgical treatment of bone and soft tissue tumours during the COVID-19 pandemic-results from an observational study at the Oxford Sarcoma Service.Int Orthop. 2020 Sep;44(9):1853-1858. doi: 10.1007/s00264-020-04736-1. Epub 2020 Jul 29. Int Orthop. 2020. PMID: 32728926 Free PMC article.
-
Myocardial infarction throughout 1 year of the COVID-19 pandemic: French nationwide study of hospitalization rates, prognosis and 90-day mortality rates.Arch Cardiovasc Dis. 2021 Dec;114(12):768-780. doi: 10.1016/j.acvd.2021.10.008. Epub 2021 Nov 10. Arch Cardiovasc Dis. 2021. PMID: 34840126 Free PMC article.
-
Management and Thinking on the Treatment of Cancer Patients During the COVID-19.Front Mol Biosci. 2021 Jul 1;8:673360. doi: 10.3389/fmolb.2021.673360. eCollection 2021. Front Mol Biosci. 2021. PMID: 34277701 Free PMC article. Review.
-
The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy.Biology (Basel). 2023 Feb 28;12(3):390. doi: 10.3390/biology12030390. Biology (Basel). 2023. PMID: 36979081 Free PMC article.
-
How Useful is COVID-19 Antibody Testing - A Current Assessment for Oncologists.Clin Oncol (R Coll Radiol). 2021 Jan;33(1):e73-e81. doi: 10.1016/j.clon.2020.10.008. Epub 2020 Oct 13. Clin Oncol (R Coll Radiol). 2021. PMID: 33350940 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous